Increased Risk of Cardiac Conduction Abnormalities with Ribociclib in Patients with Metastatic Breast Cancer: A Combined Analysis of Phase III Randomized Controlled Trials

Publication date: Available online 5 May 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Somedeb Ball, Sriman Swarup, Anita Sultan, Kyaw Zin Thein
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research